Real-World Efficacy and Safety of Mycophenolate Mofetil in Active Moderate-to-Sight-Threatening Thyroid Eye Disease
Nicole Quah Qin Xian,1 Ahmed Alnahrawy,2 Rashmi Akshikar,2 Vickie Lee2,3 1Department of Stroke Medicine, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK; 2Department of Ophthalmology, Western Eye Hospital, Imperial College Healthcare NHS Trust, London, UK; 3Department of Su...
Guardado en:
Autores principales: | Quah Qin Xian N, Alnahrawy A, Akshikar R, Lee V |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/028d212c3bfa4d0dbc4c9c8354d162ff |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Endoscopic Orbital Decompression for Graves’ Orbitopathy – A Vietnam Study
por: Pham TMH, et al.
Publicado: (2021) -
Clinical, Hormonal, and Ultrasound Characteristics of Patients with Newly Diagnosed Graves’ Disease And Different Thyroid Antibody Profiles
por: Mekova R., et al.
Publicado: (2019) -
Evaluation of the association between subconjunctival orbital fat prolapse and thyroid-associated orbitopathy
por: Han SB
Publicado: (2017) -
Clinical course of thyroid function and thyroid associated-ophthalmopathy in patients with euthyroid Graves’ disease
por: Suzuki N, et al.
Publicado: (2018) -
Clinical and imaging evaluation of the response to intravenous steroids in patients with Graves’ orbitopathy and analysis on who requires additional therapy
por: Tsirouki T, et al.
Publicado: (2016)